Simplify Logo

Full-Time

Molecular Lab Supervisor

Tuesday-Friday, 9:30pm-8:00am

Updated on 9/10/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Mid, Senior

Durham, NC, USA

Category
Genomics
Lab & Research
Biology Lab & Research
Biology & Biotech
Required Skills
Communications
Quality Assurance (QA)
Requirements
  • MS in the Biological sciences with at least three years of experience or BS in the biological sciences with at least five years of experience
  • Ability to maintain the confidentiality of patient related materials in compliance with HIPAA requirements
  • Excellent communication skills
  • Thrives in a fast-paced environment
  • Must have experience working in a molecular lab; prefer experience with next-generation sequencing
  • Ability to work with others to plan and carry out scientific programs
  • Self-driven and works well in an interdisciplinary team with minimal direction
  • Strong desire to build products that will save lives and change the course of cancer
Responsibilities
  • Provide daily oversight of a cutting-edge molecular workflow to provide high-quality next-generation sequencing data with rapid turnaround times, including tumor genomic, germline genomic, and transcriptomic sequencing
  • Establish and maintain appropriate QC and QA programs
  • Maintain CLIA and CAP compliance regarding equipment, reagents, and staff training
  • Complete quality review of all samples within the NGS workflow from extraction to sequencing
  • Balance turnaround time while optimizing costs of sequencing workflow
  • Schedule training and competency assessments for personnel
  • Mentor junior staff

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

12%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.